Similar Search Results

Schnell, Gerald - 2002

Persistent link: https://www.econbiz.de/10001668555

Reference pricing and cost-sharing : theory and evidence on German off-patent drugs ; conference paper

Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - 2014

-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …

Persistent link: https://www.econbiz.de/10010489291

Pharmaceutical cost-sharing systems and savings for health care systems from parallel trade

Birg, Laura - 2013

This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems - coinsurance and indemnity insurance - are compared with respect to changes in copayments and public health...

Persistent link: https://www.econbiz.de/10010223102

Dealing with excessive off-label drug use : liability vs. patent prolongation

Felder, Stefan; Olbrich, Anja - 2009

liability threat reduces the demand for off-label use, giving manufacturers an appropriate incentive to invest in extended … approval. By contrast, patent prolongation does not affect physicians' prescription decisions and increases the likelihood of …

Persistent link: https://www.econbiz.de/10003847110

The international provision of pharmaceuticals: a comparison of two alternative theoretical strategies for global ethics

Pies, Ingo; Hielscher, Stefan - 2007

they conceptualise and consecutively propose to solve the problem of providing life-saving pharmaceuticals to the poor in … countries hinder the poor from expressing their needs as actual demand on the market. From a theory point of view, the major …